RORC and psoriasis: Finally, while other RORγ inverse agonists have been used systemically to modulate cytokine expression in the IMQ mouse model or in vitro with isolated mononuclear cells from psoriasis patients [30], this report is the first demonstration of in vivo and ex vivo efficacy of an RORγ inverse agonist delivered topically.